Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations

Recent studies show an increased frequency of mutations in the glucocerebrosidase gene (GBA1) in patients with alpha-synucleinopathies including Parkinson disease. Some patients with Gaucher disease (GD) develop parkinsonism with et-synuclein-positive inclusions post mortem. Proteins were extracted from the cerebral cortex of subjects with synucleinopathies with and without GBA1 mutations, controls and patients with GD. Patients with GBA1-associated synucleinopathies showed aggregation of oligomeric forms of alpha-synuclein in the SOS-soluble fraction, while only monomeric forms of alpha-synuclein were seen in subjects with GBA1 mutations without parkinsonism. Thus, brains from patients with GBA1-associated parkinsonism show biochemical characteristics typical of Lewy body disorders. Published by Elsevier Inc.